-
Global Hepatitis Drugs Market Outlook 2025-2034: Growth Drivers, Share, And Trends
04 Feb 2025 06:18 GMT
… hepatitis prevention and treatment, advancements in personalized medicine for hepatitis, and expanded access to hepatitis drugs … of the hepatitis virus. The FDA Fast Track … Nucleoside Analogue Antivirals: Adefovir, Entecavir, Lamivudine
8) By Thrombopoiesis …
-
Study evaluates effectiveness and safety of TMF for chronic hepatitis B
17 Jan 2025 18:11 GMT
… from prior antiviral therapies (entecavir or TDF) to TMF … response or safety concerns. Treatment response was evaluated in … does not affect antiviral treatment outcomes.
Source:
Journal reference … Amibufenamide in the Treatment of Chronic Hepatitis B: A Real …
-
Hepatitis B Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight
17 Dec 2024 16:26 GMT
… , Nucorion Pharmaceuticals, Jiangsu HengRui Medicine, Enanta Pharmaceuticals, Chong Kun Dang Pharmaceutical, Guangzhou Lupeng Pharmaceutical, VenatoRx Pharmaceuticals … , and those who inject drugs.
Treatment for Hepatitis B focuses on reducing liver …
-
DHHS Updates Hepatitis B Guidelines for People With HIV
18 Dec 2024 20:12 GMT
… entecavir (Baraclude). Switching to the dolutegravir/lamivudine combination pill (Dovato) without additional hepatitis … B treatment should be … (Cabenuva), as neither drug is active against HHBV. …
-
nChroma Bio Raises $75M to Advance Epigenetic Editing for Hepatitis B and D Cure
13 Dec 2024 20:37 GMT
… difficult. Antiviral treatments like tenofovir and entecavir can suppress HBV … including through injection drug use, unsterile medical procedures, and, … who inject drugs, individuals with HIV or hepatitis C, and … CRMA-1001 into clinical trials in 2025. The …
-
Hopes for hepatitis B ‘cure’ with China-led treatment advance
11 Dec 2024 02:05 GMT
… The New England Journal of Medicine (NEJM).
Hepatitis B is a lifelong … to cure.
Antiviral drugs such as tenofovir or entecavir – the traditional therapeutics … , and most people who start treatment must continue it for life.
-
Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis
22 Oct 2024 20:05 GMT
… sustainable, commercial-stage biotechnology company with clinical … (hydronidone) for Chronic Hepatitis B (“CHB”)-associated … in addition to entecavir antiviral basic therapy … Drug Evaluation in March 2021. Gyre Pharmaceuticals is also developing treatments …
-
Human medicines European public assessment report (EPAR): Baraclude, entecavir, Date of authorisation: 26/06/2006, Revision: 28, Status: Authorised
05 Jul 2024 11:15 GMT
Treatment with Baraclude should be started by a doctor with experience in the management … of chronic hepatitis B.
Baraclude is … on the use of the medicine in children, see the summary …
-
Aligos Therapeutics Announces U.S. FDA Clearance of IND Application for ALG-000184
22 Oct 2024 12:00 GMT
… trials. ALG-000184 is the first novel, oral drug candidate for the treatment … 2 study. This clinical trial will be a randomized, … QD x ≤96 weeks ± Entecavir (ETV) and ALG-000184 monotherapy … with high unmet medical need such as hepatitis B and coronaviruses …
-
RNA Sequencing Analysis of Patients with Chronic Hepatitis B Treated Using PEGylated Interferon
01 Oct 2024 05:24 GMT
… (TAF), tenofovir (TDF), telbivudine (LdT), entecavir (ETV), adefovir (ADV), and lamivudine … interferon for the treatment of hepatitis B. Expert Opin Drug Metab Toxicol. 2019 … sequencing and empowering personalised cancer medicine. Drug Discov Today. 2015;20(12 …